Cocrystal Pharma Stock Forecast - Accumulation Distribution

COCP Stock  USD 1.53  0.02  1.29%   
Cocrystal Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cocrystal Pharma stock prices and determine the direction of Cocrystal Pharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cocrystal Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Cocrystal Pharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Cocrystal Pharma's systematic risk associated with finding meaningful patterns of Cocrystal Pharma fundamentals over time.
Check out Historical Fundamental Analysis of Cocrystal Pharma to cross-verify your projections.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.
  
At this time, Cocrystal Pharma's Inventory Turnover is relatively stable compared to the past year. As of 05/02/2024, Fixed Asset Turnover is likely to grow to 3.10, though Payables Turnover is likely to grow to (1.08). . As of 05/02/2024, Common Stock Shares Outstanding is likely to grow to about 13.1 M, while Net Loss is likely to drop (36.7 M).
Cocrystal Pharma has current Accumulation Distribution of 1152.25.
Most investors in Cocrystal Pharma cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Cocrystal Pharma's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Cocrystal Pharma's price structures and extracts relationships that further increase the generated results' accuracy.
The accumulation distribution (A/D) indicator shows the degree to which Cocrystal Pharma is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Cocrystal Pharma to determine if accumulation or reduction is taking place in the market. This value is adjusted by Cocrystal Pharma trading volume to give more weight to distributions with higher volume over lower volume.
Check Cocrystal Pharma VolatilityBacktest Cocrystal PharmaInformation Ratio  

Cocrystal Pharma Trading Date Momentum

On May 01 2024 Cocrystal Pharma was traded for  1.53  at the closing time. The top price for the day was 1.60  and the lowest listed price was  1.52 . The trading volume for the day was 23 K. The trading history from May 1, 2024 did not affect price variability. The overall trading delta against the current closing price is 4.58% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Cocrystal Pharma to competition

Other Forecasting Options for Cocrystal Pharma

For every potential investor in Cocrystal, whether a beginner or expert, Cocrystal Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cocrystal Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cocrystal. Basic forecasting techniques help filter out the noise by identifying Cocrystal Pharma's price trends.

Cocrystal Pharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cocrystal Pharma stock to make a market-neutral strategy. Peer analysis of Cocrystal Pharma could also be used in its relative valuation, which is a method of valuing Cocrystal Pharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Cocrystal Pharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cocrystal Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cocrystal Pharma's current price.

Cocrystal Pharma Market Strength Events

Market strength indicators help investors to evaluate how Cocrystal Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cocrystal Pharma shares will generate the highest return on investment. By undertsting and applying Cocrystal Pharma stock market strength indicators, traders can identify Cocrystal Pharma entry and exit signals to maximize returns.

Cocrystal Pharma Risk Indicators

The analysis of Cocrystal Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cocrystal Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cocrystal stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Cocrystal Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Cocrystal Stock

  0.44LMAT LeMaitre Vascular Financial Report 7th of May 2024 PairCorr
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cocrystal Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cocrystal Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cocrystal Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Cocrystal Pharma Stock:
Check out Historical Fundamental Analysis of Cocrystal Pharma to cross-verify your projections.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.
Note that the Cocrystal Pharma information on this page should be used as a complementary analysis to other Cocrystal Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Cocrystal Stock analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Cocrystal Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cocrystal Pharma. If investors know Cocrystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cocrystal Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.87)
Revenue Per Share
0.006
Quarterly Revenue Growth
0.269
Return On Assets
(0.37)
Return On Equity
(0.55)
The market value of Cocrystal Pharma is measured differently than its book value, which is the value of Cocrystal that is recorded on the company's balance sheet. Investors also form their own opinion of Cocrystal Pharma's value that differs from its market value or its book value, called intrinsic value, which is Cocrystal Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cocrystal Pharma's market value can be influenced by many factors that don't directly affect Cocrystal Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cocrystal Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cocrystal Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cocrystal Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.